{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:53:34Z","timestamp":1794243214665,"version":"4.9.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFC2600200"],"award-info":[{"award-number":["2021YFC2600200"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s12072-023-10637-3","type":"journal-article","created":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T09:01:52Z","timestamp":1709974912000},"page":"817-832","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections"],"prefix":"10.1007","volume":"18","author":[{"given":"Tao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sombat","family":"Treeprasertsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmas Rinaldi Adithya","family":"Lesmana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamun","family":"Al-mahtab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh K.","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soek-Siam","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Horng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Fung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Huei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Alcantara-Payawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaigham","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasim","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhi","family":"Mahiwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jidong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S.","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv K.","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2027-9593","authenticated-orcid":false,"given":"Qin","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,9]]},"reference":[{"key":"10637_CR1","first-page":"30","volume":"151","author":"D Houssin","year":"1980","unstructured":"Houssin D, Franco D, Corlette MB, Bismuth H. Criteria for hepatic transplantation in cirrhosis. Surg Gynecol Obstet. 1980;151:30\u201332","journal-title":"Surg Gynecol Obstet"},{"key":"10637_CR2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.cld.2018.06.004","volume":"22","author":"YH Pham","year":"2018","unstructured":"Pham YH, Miloh T. Liver transplantation in children. Clin Liver Dis. 2018;22:807\u2013821","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10637_CR3","first-page":"389","volume":"10","author":"T Chen","year":"2017","unstructured":"Chen T, Ning Q. Highlights of diagnosis and treatment for end stage of liver disease with infection. Chin J Clin Infect Dis. 2017;10(5):389\u2013393","journal-title":"Chin J Clin Infect Dis"},{"issue":"1246\u20131256","key":"10637_CR4","first-page":"1256.e1241","volume":"139","author":"V Arvaniti","year":"2010","unstructured":"Arvaniti V, D\u2019Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139(1246\u20131256):1256.e1241\u20131245","journal-title":"Gastroenterology"},{"key":"10637_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1055\/s-0038-1657751","volume":"38","author":"L Yang","year":"2018","unstructured":"Yang L, Wu T, Li J, Li J. Bacterial infections in acute-on-chronic liver failure. Semin Liver Dis. 2018;38:121\u2013133","journal-title":"Semin Liver Dis"},{"key":"10637_CR6","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018;69:406\u2013460.","DOI":"10.1016\/j.jhep.2018.03.024"},{"key":"10637_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s11938-019-00229-2","volume":"17","author":"S Ekpanyapong","year":"2019","unstructured":"Ekpanyapong S, Reddy KR. Infections in cirrhosis. Curr Treat Options Gastroenterol. 2019;17:254\u2013270","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10637_CR8","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","volume":"60","author":"R Jalan","year":"2014","unstructured":"Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL special conference 2013. J Hepatol. 2014;60:1310\u20131324","journal-title":"J Hepatol"},{"key":"10637_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/liv.13195","volume":"37","author":"F Salerno","year":"2017","unstructured":"Salerno F, Borzio M, Pedicino C, Simonetti R, Rossini A, Boccia S, et al. The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study. Liver Int. 2017;37:71\u201379","journal-title":"Liver Int"},{"key":"10637_CR10","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/jgh.13799","volume":"32","author":"A Choudhury","year":"2017","unstructured":"Choudhury A, Kumar M, Sharma BC, Maiwall R, Pamecha V, Moreau R, et al. Systemic inflammatory response syndrome in acute-on-chronic liver failure: relevance of 'golden window\u2019: a prospective study. J Gastroenterol Hepatol. 2017;32:1989\u20131997","journal-title":"J Gastroenterol Hepatol"},{"key":"10637_CR11","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/hep.28740","volume":"64","author":"J Cl\u00e0ria","year":"2016","unstructured":"Cl\u00e0ria J, Stauber RE, Coenraad MJ, Moreau R, Jalan R, Pavesi M, et al. Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure. Hepatology. 2016;64:1249\u20131264","journal-title":"Hepatology"},{"key":"10637_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jhep.2022.09.005","volume":"78","author":"A Zanetto","year":"2023","unstructured":"Zanetto A, Pelizzaro F, Campello E, Bulato C, Balcar L, Gu W, et al. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis. J Hepatol. 2023;78:301\u2013311","journal-title":"J Hepatol"},{"key":"10637_CR13","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1001\/jama.299.10.1166","volume":"299","author":"CL Wong","year":"2008","unstructured":"Wong CL, Holroyd-Leduc J, Thorpe KE, Straus SE. Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? JAMA. 2008;299:1166\u20131178","journal-title":"JAMA"},{"key":"10637_CR14","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.3748\/wjg.v24.i38.4311","volume":"24","author":"E Righi","year":"2018","unstructured":"Righi E. Management of bacterial and fungal infections in end stage liver disease and liver transplantation: current options and future directions. World J Gastroenterol. 2018;24:4311\u20134329","journal-title":"World J Gastroenterol"},{"key":"10637_CR15","first-page":"91","volume":"25","author":"T Ascione","year":"2017","unstructured":"Ascione T, Di Flumeri G, Boccia G, De Caro F. Infections in patients affected by liver cirrhosis: an update. Infez Med. 2017;25:91\u201397","journal-title":"Infez Med"},{"key":"10637_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.amjms.2020.12.009","volume":"361","author":"B Moldoveanu","year":"2021","unstructured":"Moldoveanu B, Gearhart AM, Jalil BA, Saad M, Guardiola JJ. Pulmonary aspergillosis: spectrum of disease. Am J Med Sci. 2021;361:411\u2013419","journal-title":"Am J Med Sci"},{"key":"10637_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.clinre.2014.02.005","volume":"38","author":"JW Park","year":"2014","unstructured":"Park JW, Lee JK, Lee KT, Lee KH, Sung YK, Kang CI. How to interpret the bile culture results of patients with biliary tract infections. Clin Res Hepatol Gastroenterol. 2014;38:300\u2013309","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10637_CR18","first-page":"10","volume":"26","author":"WW Luo","year":"2018","unstructured":"Luo WW, Zhang DZ. Diagnosis and treatment of bacterial infection in patients with end-stage liver disease. Zhonghua Gan Zang Bing Za Zhi. 2018;26:10\u201312","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"11","key":"10637_CR19","first-page":"863","volume":"22","author":"S Ding","year":"2014","unstructured":"Ding S, Du N, Yang W, Niu J. The current status of bacterial infections and management in decompensated cirrhosis. Chin J Hepatol. 2014;22(11):863\u2013865","journal-title":"Chin J Hepatol"},{"key":"10637_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ajg.2017.09.005","volume":"18","author":"H El-Amin","year":"2017","unstructured":"El-Amin H, Sabry AMM, Ahmed RE, Makhlouf NA. Types and microbiological spectrum of infections in patients with cirrhosis: a single-centre experience in upper Egypt. Arab J Gastroenterol. 2017;18:159\u2013164","journal-title":"Arab J Gastroenterol"},{"issue":"11","key":"10637_CR21","first-page":"863","volume":"22","author":"D Shengnan","year":"2014","unstructured":"Shengnan D, Na D, Weiming Y, Junqi N. The current status of bacterial infections and management in decompensated cirrhosis. Chin J Hepatol. 2014;22(11):863\u2013865","journal-title":"Chin J Hepatol"},{"key":"10637_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jhep.2014.03.021","volume":"61","author":"M Bartoletti","year":"2014","unstructured":"Bartoletti M, Giannella M, Caraceni P, Domenicali M, Ambretti S, Tedeschi S, et al. Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. J Hepatol. 2014;61:51\u201358","journal-title":"J Hepatol"},{"key":"10637_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/00001574-200101000-00002","volume":"17","author":"A Fasano","year":"2001","unstructured":"Fasano A. Bacterial infections: small intestine and colon. Curr Opin Gastroenterol. 2001;17:4\u20139","journal-title":"Curr Opin Gastroenterol"},{"key":"10637_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/MAJ.0b013e3181ee988d","volume":"340","author":"CM Su","year":"2010","unstructured":"Su CM, Chang WN, Tsai NW, Huang CR, Wang HC, Lu CH. Clinical features and outcome of community-acquired bacterial meningitis in adult patients with liver cirrhosis. Am J Med Sci. 2010;340:452\u2013456","journal-title":"Am J Med Sci"},{"key":"10637_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/gut.22.3.203","volume":"22","author":"O Epstein","year":"1981","unstructured":"Epstein O, Dick R, Sherlock S. Prospective study of periostitis and finger clubbing in primary biliary cirrhosis and other forms of chronic liver disease. Gut. 1981;22:203\u2013206","journal-title":"Gut"},{"key":"10637_CR26","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1097\/MEG.0000000000001155","volume":"30","author":"M Allaire","year":"2018","unstructured":"Allaire M, Cadranel JD, Bureau C, Zerkly S, Th\u00e9venot T, Garioud A, et al. Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control study. Eur J Gastroenterol Hepatol. 2018;30:1216\u20131223","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10637_CR27","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/IAE.0b013e318228e312","volume":"32","author":"S Lee","year":"2012","unstructured":"Lee S, Um T, Joe SG, Hwang JU, Kim JG, Yoon YH, et al. Changes in the clinical features and prognostic factors of endogenous endophthalmitis: fifteen years of clinical experience in Korea. Retina. 2012;32:977\u2013984","journal-title":"Retina"},{"key":"10637_CR28","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.3390\/cells9122632","volume":"9","author":"M Casulleras","year":"2020","unstructured":"Casulleras M, Zhang IW, L\u00f3pez-Vicario C, Cl\u00e0ria J. Leukocytes, systemic inflammation and immunopathology in acute-on-chronic liver failure. Cells. 2020;9:2632","journal-title":"Cells"},{"key":"10637_CR29","doi-asserted-by":"publisher","first-page":"2056168","DOI":"10.1155\/2020\/2056168","volume":"2020","author":"X He","year":"2020","unstructured":"He X, Gao Y, Liu Q, Zhao Z, Deng W, Yang H. Diagnostic value of interferon-gamma release assays combined with multiple indicators for tuberculous peritonitis. Gastroenterol Res Pract. 2020;2020:2056168","journal-title":"Gastroenterol Res Pract"},{"key":"10637_CR30","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/hep.29003","volume":"65","author":"P Tandon","year":"2017","unstructured":"Tandon P, Raman M, Mourtzakis M, Merli M. A practical approach to nutritional screening and assessment in cirrhosis. Hepatology. 2017;65:1044\u20131057","journal-title":"Hepatology"},{"key":"10637_CR31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/ageing\/afz046","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:601","journal-title":"Age Ageing"},{"key":"10637_CR32","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1016\/j.clnu.2020.09.001","volume":"39","author":"SC Bischoff","year":"2020","unstructured":"Bischoff SC, Bernal W, Dasarathy S, Merli M, Plank LD, Sch\u00fctz T, et al. ESPEN practical guideline: clinical nutrition in liver disease. Clin Nutr. 2020;39:3533\u20133562","journal-title":"Clin Nutr"},{"key":"10637_CR33","unstructured":"Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Gastroenterology, Chinese Medical Association. Clinical guidelines on nutrition in end-stage liver disease. Chin J Hepatol, 2019;27:330\u2013342."},{"key":"10637_CR34","unstructured":"Beijing Medical Association, Committee of Parenteral and Enteral nutrition, Expert Panel on Consensus on the Parenteral and Enteral nutrition and the Dietary Intervention for Patients with Chronic Liver Diseases. Consensus on the clinical nutritional intervention for patients with chronic liver diseases. Chin J Hepatobiliary Surgery 2017;33:73\u201381."},{"key":"10637_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/apt.15571","volume":"51","author":"C Bunchorntavakul","year":"2020","unstructured":"Bunchorntavakul C, Reddy KR. Review article: malnutrition\/sarcopenia and frailty in patients with cirrhosis. Aliment Pharmacol Ther. 2020;51:64\u201377","journal-title":"Aliment Pharmacol Ther"},{"key":"10637_CR36","unstructured":"Liver Failure and Artificial Liver Group C S O I D, Chinese Medical Association, Severe Liver Disease and Artificial Liver Group C S O H, Chinese Medical Association. Consensus statement by the expert committee for prevention and management of liver inflammation in China. Chin J Hepatol 2014;22:94\u2013103."},{"key":"10637_CR37","first-page":"18","volume":"27","author":"Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association, Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association","year":"2019","unstructured":"Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association, Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure. Chin J Hepatol. 2019;27:18\u201326","journal-title":"Chin J Hepatol"},{"key":"10637_CR38","first-page":"498","volume":"59","author":"JX Wang","year":"2020","unstructured":"Chinese Society of Internal Medicine, Chinese Medical Association, Wang JX, Zhang FC, Liu XQ, Tang CW, Chen LA, et al. Expert consensus for diagnosis and treatment of thrombocytopenia in China. Chin J Intern Med. 2020;59:498\u2013510","journal-title":"Chin J Intern Med"},{"key":"10637_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1620\/tjem.229.213","volume":"229","author":"T Maruyama","year":"2013","unstructured":"Maruyama T, Murata S, Takahashi K, Tamura T, Nozaki R, Ikeda N, et al. Platelet transfusion improves liver function in patients with chronic liver disease and cirrhosis. Tohoku J Exp Med. 2013;229:213\u2013220","journal-title":"Tohoku J Exp Med"},{"key":"10637_CR40","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1053\/j.gastro.2018.05.025","volume":"155","author":"N Terrault","year":"2018","unstructured":"Terrault N, Chen YC, Izumi N, Kayali Z, Mitrut P, Tak WY, et al. Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia. Gastroenterology. 2018;155:705\u2013718","journal-title":"Gastroenterology"},{"key":"10637_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/HMER.S264231","volume":"12","author":"G Zaccherini","year":"2020","unstructured":"Zaccherini G, Tufoni M, Bernardi M. Albumin administration is efficacious in the management of patients with cirrhosis: a systematic review of the literature. Hepat Med. 2020;12:153\u2013172","journal-title":"Hepat Med"},{"key":"10637_CR42","first-page":"111","volume":"32","author":"JM Dwyer","year":"1987","unstructured":"Dwyer JM. Intravenous therapy with gamma globulin. Adv Intern Med. 1987;32:111\u2013135","journal-title":"Adv Intern Med"},{"key":"10637_CR43","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12876-020-01477-8","volume":"20","author":"D Peng","year":"2020","unstructured":"Peng D, Xing HY, Li C, Wang XF, Hou M, Li B, et al. The clinical efficacy and adverse effects of entecavir plus thymosin alpha-1 combination therapy versus entecavir monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis. BMC Gastroenterol. 2020;20:348","journal-title":"BMC Gastroenterol"},{"key":"10637_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12072-014-9588-7","volume":"9","author":"D Xu","year":"2015","unstructured":"Xu D, Zhao M, Song Y, Song J, Huang Y, Wang J. Novel insights in preventing Gram-negative bacterial infection in cirrhotic patients: review on the effects of GM-CSF in maintaining homeostasis of the immune system. Hepatol Int. 2015;9:28\u201334","journal-title":"Hepatol Int"},{"key":"10637_CR45","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1586\/1744666X.2015.1024110","volume":"11","author":"JA Hamilton","year":"2015","unstructured":"Hamilton JA. GM-CSF as a target in inflammatory\/autoimmune disease: current evidence and future therapeutic potential. Expert Rev Clin Immunol. 2015;11:457\u2013465","journal-title":"Expert Rev Clin Immunol"},{"key":"10637_CR46","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s12072-022-10314-x","volume":"16","author":"A Venkitaraman","year":"2022","unstructured":"Venkitaraman A, De A, Verma N, Kumari S, Leishangthem B, Sharma RR, et al. Multiple cycles of granulocyte colony-stimulating factor in decompensated cirrhosis: a double-blind RCT. Hepatol Int. 2022;16:1127\u20131136","journal-title":"Hepatol Int"},{"key":"10637_CR47","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/hep.29763","volume":"68","author":"N Verma","year":"2018","unstructured":"Verma N, Kaur A, Sharma R, Bhalla A, Sharma N, De A, et al. Outcomes after multiple courses of granulocyte colony-stimulating factor and growth hormone in decompensated cirrhosis: a randomized trial. Hepatology. 2018;68:1559\u20131573","journal-title":"Hepatology"},{"key":"10637_CR48","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/liv.15534","volume":"43","author":"V Prakash","year":"2023","unstructured":"Prakash V, Arora V, Jindal A, Maiwall R, Sarin SK. Combination of GM CSF and carbapenem is superior to carbapenem monotherapy in difficult-to-treat spontaneous bacterial peritonitis: a randomized controlled trial. Liver Int. 2023;43:1298\u20131306","journal-title":"Liver Int"},{"key":"10637_CR49","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1080\/17474124.2019.1688143","volume":"13","author":"F Chen","year":"2019","unstructured":"Chen F, Shi Y, Liu X, Lei L, Xu J. Corticosteroid improves liver function but does not curb the clinical progression of hepatitis B virus-related acute-on-chronic pre-liver failure. Expert Rev Gastroenterol Hepatol. 2019;13:1129\u20131135","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10637_CR50","doi-asserted-by":"publisher","first-page":"593","DOI":"10.51821\/85.4.10728","volume":"85","author":"P Shi","year":"2022","unstructured":"Shi P, Zhu WT, Liang A, Wan J, Fu JW, Wu XP. Efficacy and predictive factors of glucocorticoid therapy for patients with hepatitis B virus-related acute-on-chronic liver failure. Acta Gastroenterol Belg. 2022;85:593\u2013600","journal-title":"Acta Gastroenterol Belg"},{"key":"10637_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353\u2013390","journal-title":"Hepatol Int"},{"key":"10637_CR52","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s12072-022-10357-0","volume":"16","author":"KC Lee","year":"2022","unstructured":"Lee KC, Cheng JS, Chang ML, Chien RN, Liaw YF. Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study. Hepatol Int. 2022;16:799\u2013806","journal-title":"Hepatol Int"},{"key":"10637_CR53","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/hup.1244","volume":"26","author":"L Leggio","year":"2011","unstructured":"Leggio L, Kenna GA, Ferrulli A, Zywiak WH, Caputo F, Swift RM, et al. Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease. Hum Psychopharmacol. 2011;26:554\u2013559","journal-title":"Hum Psychopharmacol"},{"key":"10637_CR54","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jceh.2022.02.001","volume":"12","author":"G Ayares","year":"2022","unstructured":"Ayares G, Idalsoaga F, D\u00edaz LA, Arnold J, Arab JP. Current medical treatment for alcohol-associated liver disease. J Clin Exp Hepatol. 2022;12:1333\u20131348","journal-title":"J Clin Exp Hepatol"},{"key":"10637_CR55","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4254\/wjh.v10.i2.254","volume":"10","author":"T Shizuma","year":"2018","unstructured":"Shizuma T. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: a literature review. World J Hepatol. 2018;10:254\u2013266","journal-title":"World J Hepatol"},{"key":"10637_CR56","doi-asserted-by":"publisher","first-page":"46025","DOI":"10.1038\/srep46025","volume":"7","author":"L Shi","year":"2017","unstructured":"Shi L, Wu D, Wei L, Liu S, Zhao P, Tu B, et al. Nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis in China: comparative microbiology and therapeutic implications. Sci Rep. 2017;7:46025","journal-title":"Sci Rep"},{"key":"10637_CR57","doi-asserted-by":"publisher","first-page":"7742","DOI":"10.3748\/wjg.v22.i34.7742","volume":"22","author":"M Fiore","year":"2016","unstructured":"Fiore M, Leone S. Spontaneous fungal peritonitis: epidemiology, current evidence and future prospective. World J Gastroenterol. 2016;22:7742\u20137747","journal-title":"World J Gastroenterol"},{"key":"10637_CR58","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10096-013-1953-2","volume":"33","author":"SY Hwang","year":"2014","unstructured":"Hwang SY, Yu SJ, Lee JH, Kim JS, Yoon JW, Kim YJ, et al. Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis. Eur J Clin Microbiol Infect Dis. 2014;33:259\u2013264","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10637_CR59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/jof4040133","volume":"4","author":"N Spernovasilis","year":"2018","unstructured":"Spernovasilis N, Kofteridis DP. Pre-existing liver disease and toxicity of antifungals. J Fungi (Basel). 2018;4:133","journal-title":"J Fungi (Basel)"},{"key":"10637_CR60","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1164\/rccm.167.4.603","volume":"167","author":"HM Blumberg","year":"2003","unstructured":"Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society\/Centers for Disease Control and prevention\/infectious diseases society of america: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167:603\u2013662","journal-title":"Am J Respir Crit Care Med"},{"key":"10637_CR61","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1365-2036.2005.02645.x","volume":"22","author":"FM Sanai","year":"2005","unstructured":"Sanai FM, Bzeizi KI. Systematic review: tuberculous peritonitis\u2013presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther. 2005;22:685\u2013700","journal-title":"Aliment Pharmacol Ther"},{"key":"10637_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1749-7922-8-3","volume":"8","author":"M Sartelli","year":"2013","unstructured":"Sartelli M, Viale P, Catena F, Ansaloni L, Moore E, Malangoni M, et al. 2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2013;8:3","journal-title":"World J Emerg Surg"},{"key":"10637_CR63","first-page":"301","volume":"39","author":"WC Liang","year":"2018","unstructured":"Liang WC, Zhu YC, Han FL, Chen QS, Chen LH. Analysis on the distribution of pathogenic bacteria in bile of patients with biliary tract infection and their sensitivity to drugs. J Med J. 2018;39:301\u2013303","journal-title":"J Med J"},{"issue":"Suppl 1","key":"10637_CR64","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/liv.13645","volume":"38","author":"S Piano","year":"2018","unstructured":"Piano S, Brocca A, Mareso S, Angeli P. Infections complicating cirrhosis. Liver Int. 2018;38(Suppl 1):126\u2013133","journal-title":"Liver Int"},{"key":"10637_CR65","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0140-6736(15)60733-4","volume":"386","author":"E Prina","year":"2015","unstructured":"Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet. 2015;386:1097\u20131108","journal-title":"Lancet"},{"key":"10637_CR66","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis. 2016;63:e61\u2013e111","journal-title":"Clin Infect Dis"},{"key":"10637_CR67","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41579-020-0324-0","volume":"18","author":"RD Klein","year":"2020","unstructured":"Klein RD, Hultgren SJ. Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies. Nat Rev Microbiol. 2020;18:211\u2013226","journal-title":"Nat Rev Microbiol"},{"key":"10637_CR68","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/cid\/ciz032","volume":"69","author":"M Bartoletti","year":"2019","unstructured":"Bartoletti M, Giannella M, Lewis RE, Caraceni P, Tedeschi S, Paul M, et al. Extended infusion of \u03b2-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study. Clin Infect Dis. 2019;69:1731\u20131739","journal-title":"Clin Infect Dis"},{"key":"10637_CR69","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2147\/IDR.S241648","volume":"13","author":"Y Dong","year":"2020","unstructured":"Dong Y, Li Y, Zhang Y, Sun D, Du Q, Zhang T, et al. Clinical efficacy and cost-effectiveness of \u03b2-lactam\/\u03b2-lactamase inhibitor combinations and carbapenems in liver cirrhosis patients with gram-negative bacteria bloodstream infection. Infect Drug Resist. 2020;13:1327\u20131338","journal-title":"Infect Drug Resist"},{"key":"10637_CR70","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12664-014-0454-2","volume":"33","author":"A Sood","year":"2014","unstructured":"Sood A, Midha V, Goyal O, Goyal P, Sood P, Sharma SK, et al. Skin and soft tissue infections in cirrhotics: a prospective analysis of clinical presentation and factors affecting outcome. Indian J Gastroenterol. 2014;33:281\u2013284","journal-title":"Indian J Gastroenterol"},{"key":"10637_CR71","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/cid\/ciu296","volume":"59","author":"DL Stevens","year":"2014","unstructured":"Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59:e10-52","journal-title":"Clin Infect Dis"},{"key":"10637_CR72","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00108-016-0183-y","volume":"58","author":"C L\u00fcbbert","year":"2017","unstructured":"L\u00fcbbert C, Mutters R. Gastrointestinal infections. Internist (Berl). 2017;58:149\u2013169","journal-title":"Internist (Berl)"},{"key":"10637_CR73","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1592\/phco.23.14.1441.31938","volume":"23","author":"A Wong-Beringer","year":"2003","unstructured":"Wong-Beringer A, Kriengkauykiat J. Systemic antifungal therapy: new options, new challenges. Pharmacotherapy. 2003;23:1441\u20131462","journal-title":"Pharmacotherapy"},{"key":"10637_CR74","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1053\/j.gastro.2014.10.023","volume":"147","author":"DW Victor 3rd","year":"2014","unstructured":"Victor DW 3rd, Quigley EM. Microbial therapy in liver disease: probiotics probe the microbiome-gut-liver-brain axis. Gastroenterology. 2014;147:1216\u20131218","journal-title":"Gastroenterology"},{"key":"10637_CR75","first-page":"649","volume":"23","author":"HA el Aggan","year":"1993","unstructured":"el Aggan HA, el-Aggan HA, Abou Seif Helmy M, Guirguis TG. Selective intestinal decontamination in patients with schistosomal hepatic fibrosis and low-protein ascites. J Egypt Soc Parasitol. 1993;23:649\u2013657","journal-title":"J Egypt Soc Parasitol"},{"key":"10637_CR76","doi-asserted-by":"publisher","first-page":"660","DOI":"10.14423\/SMJ.0000000000000887","volume":"111","author":"A Oliver","year":"2018","unstructured":"Oliver A, Wong M, Sanchez C. Role of rifaximin in spontaneous bacterial peritonitis prevention. South Med J. 2018;111:660\u2013665","journal-title":"South Med J"},{"key":"10637_CR77","doi-asserted-by":"publisher","first-page":"380","DOI":"10.2174\/1389450119666180924145156","volume":"20","author":"A Menshawy","year":"2019","unstructured":"Menshawy A, Mattar O, Barssoum K, AboEl-Naga AM, Salim HM, Mohamed AMF, et al. Safety and efficacy of rifaximin in prophylaxis of spontaneous bacterial peritonitis: a systematic review and meta-analysis. Curr Drug Targets. 2019;20:380\u2013387","journal-title":"Curr Drug Targets"},{"key":"10637_CR78","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1038\/s41598-021-82719-x","volume":"11","author":"P Li","year":"2021","unstructured":"Li P, Liang X, Xu S, Xiong Y, Huang J. A non-bioartificial liver support system combined with transplantation in HBV-related acute-on-chronic liver failure. Sci Rep. 2021;11:2975","journal-title":"Sci Rep"},{"key":"10637_CR79","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.cgh.2020.06.051","volume":"19","author":"YW Cheng","year":"2021","unstructured":"Cheng YW, Alhaffar D, Saha S, Khanna S, Bohm M, Phelps E, et al. Fecal microbiota transplantation is safe and effective in patients with clostridioides difficile infection and cirrhosis. Clin Gastroenterol Hepatol. 2021;19:1627\u20131634","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10637_CR80","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/MCC.0000000000000584","volume":"25","author":"FS Larsen","year":"2019","unstructured":"Larsen FS. Artificial liver support in acute and acute-on-chronic liver failure. Curr Opin Crit Care. 2019;25:187\u2013191","journal-title":"Curr Opin Crit Care"},{"key":"10637_CR81","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13613-018-0453-z","volume":"8","author":"JJ Garc\u00eda Mart\u00ednez","year":"2018","unstructured":"Garc\u00eda Mart\u00ednez JJ, Bendjelid K. Artificial liver support systems: what is new over the last decade? Ann Intensive Care. 2018;8:109","journal-title":"Ann Intensive Care"},{"key":"10637_CR82","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.jhep.2017.11.008","volume":"68","author":"M Linecker","year":"2018","unstructured":"Linecker M, Krones T, Berg T, Niemann CU, Steadman RH, Dutkowski P, et al. Potentially inappropriate liver transplantation in the era of the \u201csickest first\u201d policy - a search for the upper limits. J Hepatol. 2018;68:798\u2013813","journal-title":"J Hepatol"},{"key":"10637_CR83","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.transproceed.2008.10.033","volume":"41","author":"BS Kim","year":"2009","unstructured":"Kim BS, Lee SG, Hwang S, Ahn CS, Kim KH, Moon DB, et al. Influence of pretransplantation bacterial and fungal culture positivity on outcome after living donor liver transplantation. Transpl Proc. 2009;41:250\u2013252","journal-title":"Transpl Proc"},{"key":"10637_CR84","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1002\/bjs.10449","volume":"104","author":"VR Bertuzzo","year":"2017","unstructured":"Bertuzzo VR, Giannella M, Cucchetti A, Pinna AD, Grossi A, Ravaioli M, et al. Impact of preoperative infection on outcome after liver transplantation. Br J Surg. 2017;104:e172\u2013e181","journal-title":"Br J Surg"},{"key":"10637_CR85","first-page":"251","volume":"113","author":"V Nikam","year":"2021","unstructured":"Nikam V, Srivastava M. The outcome of living donor liver transplant recipients with recent episodes of spontaneous bacterial peritonitis. Rev Esp Enferm Dig. 2021;113:251\u2013254","journal-title":"Rev Esp Enferm Dig"},{"issue":"8","key":"10637_CR86","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3390\/antibiotics12081316","volume":"12","author":"R Taddei","year":"2023","unstructured":"Taddei R, Riccardi N, Tiseo G, Galfo V, Biancofiore G. Early intra-abdominal bacterial infections after orthotopic liver transplantation: a narrative review for clinicians. Antibiotics (Basel). 2023;12(8):1316","journal-title":"Antibiotics (Basel)"},{"issue":"82","key":"10637_CR87","volume":"8","author":"N Bayramov","year":"2022","unstructured":"Bayramov N, Mammadova S. A review of the current ERAS guidelines for liver resection, liver transplantation and pancreatoduodenectomy. Ann Med Surg (Lond). 2022;8(82): 104596","journal-title":"Ann Med Surg (Lond)"},{"issue":"25","key":"10637_CR88","volume":"19","author":"W Zhang","year":"2020","unstructured":"Zhang W, Wang W, Kang M, Wu S, Liu Y, Liao Q, et al. Bacterial and fungal infections after liver transplantation: microbial epidemiology, risk factors for infection and death with infection. Ann Transpl. 2020;19(25): e921591","journal-title":"Ann Transpl"},{"key":"10637_CR89","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s12072-012-9344-9","volume":"6","author":"K Ma","year":"2012","unstructured":"Ma K, Guo W, Han M, Chen G, Chen T, Wu Z, et al. Entecavir treatment prevents disease progression in hepatitis B virus-related acute-on-chronic liver failure: establishment of a novel logistical regression model. Hepatol Int. 2012;6:735\u2013743","journal-title":"Hepatol Int"},{"key":"10637_CR90","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12072-013-9485-5","volume":"8","author":"J Wang","year":"2014","unstructured":"Wang J, Ma K, Han M, Guo W, Huang J, Yang D, et al. Nucleoside analogs prevent disease progression in HBV-related acute-on-chronic liver failure: validation of the TPPM model. Hepatol Int. 2014;8:64\u201371","journal-title":"Hepatol Int"},{"key":"10637_CR91","doi-asserted-by":"publisher","first-page":"199","DOI":"10.14740\/gr1255","volume":"13","author":"S Habib","year":"2020","unstructured":"Habib S, Yarlagadda S, Carreon TA, Schader LM, Hsu CH. Fungal infection in acutely decompensated cirrhosis patients: value of model for end-stage liver disease score. Gastroenterology Res. 2020;13:199\u2013207","journal-title":"Gastroenterology Res"},{"key":"10637_CR92","doi-asserted-by":"publisher","first-page":"8596567","DOI":"10.1155\/2020\/8596567","volume":"2020","author":"CC Hung","year":"2020","unstructured":"Hung CC, Hsu YC, Lin KH. Comparing mortality risk predictive ability of different scoring systems in cirrhotic patients with bacteremia. Emerg Med Int. 2020;2020:8596567","journal-title":"Emerg Med Int"},{"key":"10637_CR93","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1136\/gutjnl-2017-314324","volume":"67","author":"S Piano","year":"2018","unstructured":"Piano S, Bartoletti M, Tonon M, Baldassarre M, Chies G, Romano A, et al. Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections. Gut. 2018;67:1892\u20131899","journal-title":"Gut"},{"key":"10637_CR94","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.diagmicrobio.2014.03.029","volume":"80","author":"KH Lin","year":"2014","unstructured":"Lin KH, Wang FL, Wu MS, Jiang BY, Kao WL, Chao HY, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis. Diagn Microbiol Infect Dis. 2014;80:72\u201378","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10637_CR95","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12072-021-10268-6","volume":"16","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Yang Z, Cheng Q, Hu X, Liu M, Liu Y, et al. Establishment and validation of a prognostic model for hepatitis B virus-related acute-on-chronic liver failure patients with bacterial infection. Hepatol Int. 2022;16:38\u201347","journal-title":"Hepatol Int"},{"key":"10637_CR96","first-page":"103","volume":"112","author":"M Merli","year":"2021","unstructured":"Merli M, Aprile F. The European association for the study of liver (EASL) nutrition guidelines. Recenti Prog Med. 2021;112:103\u2013109","journal-title":"Recenti Prog Med"},{"key":"10637_CR97","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3390\/ijerph17051727","volume":"17","author":"D Piotrowski","year":"2020","unstructured":"Piotrowski D, S\u0105czewska-Piotrowska A, Jaroszewicz J, Boro\u0144-Kaczmarska A. Lymphocyte-To-monocyte ratio as the best simple predictor of bacterial infection in patients with liver cirrhosis. Int J Environ Res Public Health. 2020;17:1727","journal-title":"Int J Environ Res Public Health"},{"key":"10637_CR98","doi-asserted-by":"crossref","first-page":"300060520919220","DOI":"10.1177\/0300060520919220","volume":"48","author":"Q Yang","year":"2020","unstructured":"Yang Q, Jiang XZ, Zhu YF, Lv FF. Clinical risk factors and predictive tool of bacteremia in patients with cirrhosis. J Int Med Res. 2020;48:300060520919220","journal-title":"J Int Med Res"},{"key":"10637_CR99","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s40121-021-00454-2","volume":"10","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Ma K, Yang Z, Cheng Q, Hu X, Liu M, et al. Development and validation of a clinical predictive model for bacterial infection in hepatitis B virus-related acute-on-chronic liver failure. Infect Dis Ther. 2021;10:1347\u20131361","journal-title":"Infect Dis Ther"},{"issue":"1","key":"10637_CR100","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/apt.16926","volume":"56","author":"L T\u00e9llez","year":"2022","unstructured":"T\u00e9llez L, S\u00e1nchez Rodr\u00edguez E, Rodr\u00edguez de Santiago E, Llovet L, G\u00f3mez-Outomuro A, D\u00edaz-Fontenla F, et al. Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study. Aliment Pharmacol Ther. 2022;56(1):131\u2013143","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10637_CR101","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/apt.17508","volume":"57","author":"D Schneider","year":"2023","unstructured":"Schneider D, Strathmore A, Yu C, Hannah N, Sood S. Letter: time to consider Pneumocystis jirovecii pneumonia prophylaxis in treatment of autoimmune hepatitis. Aliment Pharmacol Ther. 2023;57(10):1210\u20131211","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10637-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-023-10637-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10637-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T01:38:58Z","timestamp":1731548338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-023-10637-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,9]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10637"],"URL":"https:\/\/doi.org\/10.1007\/s12072-023-10637-3","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,9]]},"assertion":[{"value":"28 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}